RHIANNON BLACK: Open Payments
NPI 1528431871 · LEXINGTON, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,341 in 108 payments from 17 companies in 2025. Trend: 2023 $3,578 · 2024 $599 · 2025 $2,341
Food & beverage: $2,256Education: $85
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 23 | $538 |
| Janssen Biotech, Inc. | 13 | $383 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 11 | $224 |
| Madrigal Pharmaceuticals | 5 | $201 |
| Phathom Pharmaceuticals, Inc. | 17 | $201 |
| GENZYME CORPORATION | 8 | $140 |
| Ardelyx, Inc. | 5 | $106 |
| Takeda Pharmaceuticals U.S.A., Inc. | 5 | $105 |
| Lilly USA, LLC | 5 | $102 |
| PFIZER INC. | 5 | $98 |
Products named: TREMFYA, RINVOQ, REZDIFFRA, VOQUEZNA, DUPIXENT, XIFAXAN, SKYRIZI, IBSRELA.
Industry payments across KY — which companies pay providers there.
